Mimetas

Activities: Analysis

Trending Articles

  1. AstraZeneca invests $3.5bn into its US pharmaceutical research and manufacturing capabilities The company will expand its biologics manufacturing, as well as its speciality manufacturing and cell therapy production capacity, while also extending its pharmaceutical...
  2. The importance of accurate tare/gross weighing systems in the pharmaceutical industry Why accurate tare/gross weighing is critical in pharmaceutical settings
  3. IMed Consultancy enabling innovation in the mental healthcare sector with Limbic Limbic is a London-based start-up that is using world-leading, clinically validated Artificial Intelligence and beautiful product design to make psychological therapy...
  4. Romaco showcases its solid dosage processing portfolio at CPHI & PMEC India The company will display its portfolio suitable for the granulation, tableting, and coating of pharmaceutical solids
  5. Lonza expands bioconjugation capabilities for ADC manufacturing at Visp site The CDMO's facility will double its bioconjugate manufacturing capacity with two 1,200 L manufacturing suites

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

Related Content

Research & Development

MIMETAS and Yamaha Motor Sign Joint Marketing Agreement Aimed at Advancing Therapeutic Development

Both companies will collaborate to develop innovative applications of the CELL HANDLER in combination with MIMETAS’ 3D tissue models
Research & Development

MIMETAS develops high-throughput gut-on-a-chip technology

MIMETAS, in collaboration with the pharmaceutical company Roche, has developed a novel organ-on-a-chip system that supports evaluation of intestinal permeability in perfused 3-D gut tubules in high throughput under exposure to pharmacological compounds, the results of the research were published in <i>Nature Communications</i>
Finance

Mimetas receives US$1.6m in funding to develop organ-on-a-chip neurotoxicity models

Aims to improve existing tests and reduce experimentation on animals
Subscribe now